Identification of a 3-Gene Model as Prognostic Biomarker in Patients With Gastric Cancer
ObjectiveAlthough the incidence of gastric cancer (GC) is decreasing, GC remains one of the leading cancers in the world. Surgical resection, radiotherapy, chemotherapy, and neoadjuvant therapy have advanced, but patients still face the risk of recurrence and poor prognosis. This study provides new...
Main Authors: | Siming Xue, Tianjiao Zheng, Juan Yan, Jinmin Ma, Cong Lin, Shichen Dong, Chen Wei, Tong Li, Xiaoyin Zhang, Guibo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.930586/full |
Similar Items
-
Investigation of the Relationship between COX-2 Expression, Clinicopathological Symptoms, and Prognosis of the Patients with Gastric Cancer
by: Abolfazl Hekmat-Shoar, et al.
Published: (2023-07-01) -
Gastric transcatheter chemoembolization can resolve advanced gastric cancer presenting with obstruction
by: Dong Peng, et al.
Published: (2022-10-01) -
Influential factors on survival in gastric cancer: A single-center study
by: Ghodratollah Roshanaei, et al.
Published: (2022-01-01) -
Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening
by: Rémy Jardillier, et al.
Published: (2022-10-01) -
Random survival forest in determination of important risk factors on overall survival and disease-free survival in gastric cancer patients
by: M. Safari, et al.
Published: (2023-07-01)